If you are undergoing or recovering from breast cancer treatments, be it surgery, chemotherapy or radiation, your main focus is on getting rid of the cancer. Nutrition can play a vital role in your treatment recovery, prevention of cancer recurrence, and overall health and well-being.
Meet a Helpline Volunteer: Dorothea
“Being a Helpline Volunteer, for me, is a way to be part of something meaningful. In many ways it is a good fit with my former work as a social worker. It is particularly gratifying if and when a caller finds our conversation helpful.”
Meet a Helpline Volunteer: Agnes Soloman
Meet Agnes, one of the volunteers on our Breast Cancer Helpline.
Diane’s Story: 6 Year Breast Cancer Survivor
My name is Diane and I am a 6 year breast cancer survivor. My story began November 2011 when I felt a slight burning sensation in my right breast. I was working as a daycare provider and neglected to do anything, hoping the burning sensation was temporary.
Talking with Your Doctor About Clinical Trials – Where to Start
If you have received a breast cancer diagnosis, your doctor may mention a clinical trial as a part of your treatment options. Clinical trials are a useful tool for researchers to learn more about current and innovative treatments in hopes to improve future treatment care.
Meet a Helpline Volunteer: Denise Z.
Why did you decide to be a SHARE Breast Cancer Helpline volunteer?
I saw a post from Tamsen Fadal on Facebook, who was at a SHARE benefit event. I’d never heard of SHARE. I contacted them and they trained me over the phone and internet. They forward the calls to me here in Orlando.
We Run For Hope 2018
Runners and walkers from around the city gathered at Flushing Meadows Park on Sunday, June 4, for the We Run for Hope 5K/10K Run and Walk. This event, held annually on National Cancer Survivors Day, is a great opportunity to support women with breast or ovarian cancer while also staying fit and active.
Most Early-Stage Breast Cancer Patients Can Safely Avoid Chemotherapy, According to Landmark TAILORx Results Presented at ASCO 2018 and Published in The New England Journal of Medicine
Seventy percent of early-stage breast cancer patients can safely forego
chemotherapy and use hormonal therapy alone (such as Arimidex®, tamoxifen or
Faslodex®), according to the long-awaited results of the landmark TAILORx (Trial
Assigning IndividuaLized Options for Treatment (Rx)) study presented at the 2018
American Society of Clinical Oncology (ASCO) Annual Meeting on June 3. The
largest-ever breast cancer treatment study, TAILORx is a prospective, randomized
clinical trial sponsored by the NCI and designed to more precisely define the
effect of chemotherapy for women with Oncotype DX Breast Recurrence Score®
results.
Rebecca’s Story: Running Through Breast Cancer
In early 2009 as I was doing a self-breast exam, I felt a lump. I wasn’t too concerned because I knew my mom had had several benign lumps and figured it was probably the same. I waited a couple of months until my next woman wellness visit. When I told my doctor about it, she felt the lump too but said women my age (34) get lumps.
SHARE’s Annual Volunteer Party
April is National Volunteer Appreciation Month, and SHARE hosted its annual volunteer party to show how much we appreciate the incredible commitment of our volunteers. It was another great gathering with a raffle, food, music, and of course, amazing company.
